LBA93 EXTENTORCH: A randomized, phase III trial of toripalimab versus placebo, in combination with chemotherapy as a first-line therapy for patients with extensive stage small cell lung cancer (ES-SCLC)

Ying Cheng, Ying Liu, W. Zhang, Lin Wu, Caicun Zhou, Dan Wang, Bairong Xia, M. Bi, Xiaorui Fu, Chunde Li, G. Chen, Dongqing Lv, Yanqiu Zhao, Jianan Huang, Ming Li, T. Yi, Xiao‐Jun Huang, Runxiang Yang, Zewen Chen, Yong Wang